Market Overview

Social Media Outlook for Thursday 17 (PCYC, DRI, MLM, SPLS)

Share:
Related PCYC
10 Biotech Stories You Might've Missed This Week
Mid-Day Market Update: Pharmacyclics Surges On Strong Preliminary 2014 Results; Fresh Market Shares Slip
FDA clears Imbruvica expanded label (Seeking Alpha)

In recent years, traders and investors have increasingly turned to social media to discuss their investments. Now, interested parties can get a scientific look at what is being discussed on a weekly, monthly, and even hourly basis.

Provided by Social Market Analytics, here is the social media outlook for Thursday, May 17.

Most Bullish

Pharmacyclics (NASDAQ: PCYC) is trading up over 3%. Rodman & Renshaw boosted the company's price target.

Darden Restaurants (NYSE: DRI)

Most Bearish

Martin Marietta (NYSE: MLM) is trading down about 1.25%. Yesterday, shares plunged when hedge fund manager David Einhorn mentioned the company as a possible short target.

Staples (NASDAQ: SPLS) is trading down over 2%.

Most Discussed

Apple (NASDAQ: AAPL) frequently sits atop this list. Shares are currently trading near $538.

JPMorgan (NYSE: JPM) continues to be discussed in the wake of the company's announcement that it had lost roughly $2 billion trading last week.

Google (NASDAQ: GOOG), like Apple, is also frequently discussed. Shares are currently trading near $632.

Herbalife (NYSE: HLF) is currently trading down over 5%. Shares spiked up higher yesterday after hedge fund manager David Einhorn failed to mention them in his presentation as expected.

Interested in getting more information about stock trends on social media? Signup for the Social Market Analytics newsletter on their website.

Latest Ratings for PCYC

DateFirmActionFromTo
Jan 2015JMP SecuritiesMaintainsMarket Outperform
Jan 2015CitigroupMaintainsBuy
Jan 2015BTIG ResearchInitiates Coverage onBuy

View More Analyst Ratings for PCYC
View the Latest Analyst Ratings

Posted-In: Earnings News Hedge Funds Price Target Analyst Ratings Movers Tech Trading Ideas Best of Benzinga

 

Related Articles (AAPL + DRI)

Around the Web, We're Loving...

Get Benzinga's Newsletters